NHS Scotland GPs and ADHD Shared Care: What to Do If Your Agreement Is Withdrawn in 2026

The landscape of adult ADHD care in Scotland has shifted dramatically. Recent reports confirm that NHS Scotland GPs are no longer accepting ADHD shared-care agreements from private providers with the same willingness seen in previous years, effectively ending the practice of private diagnosis queue jumping that many patients relied upon. For the thousands of adults who sought a private assessment to bypass waiting lists stretching to eighteen months or more, this change has created a frightening new reality: a diagnosis in hand but no NHS prescription to treat it. This article explains exactly why this is happening, what the Scottish guidance means for your treatment, and the practical steps you can take if your shared care agreement has been withdrawn or refused.

The Shared Care Crisis in Scotland: Why GPs Are Saying No

A shared care agreement is the bridge between private diagnosis and NHS treatment. Under such an arrangement, a private psychiatrist initiates and stabilises your ADHD medication, then transfers the routine prescribing responsibility to your NHS GP. The GP issues repeat prescriptions at NHS prescription charge rates, while the private specialist retains oversight through periodic reviews. Without this agreement, patients must pay for private prescriptions outright, a cost that frequently exceeds £200 per month.

The specific trigger for the current crisis in Scotland is the 2022 guidance issued by the National Advisory Group for ADHD, known as NAIT. This document set out detailed clinical standards that private assessments must meet before a GP can confidently enter into a shared care arrangement. In the years since its publication, Scottish health boards have increasingly interpreted the guidance as grounds for refusal, and by 2025 and into 2026, the trickle of rejections has become a steady stream of withdrawals.

There is also a cultural factor at play. Within NHS Scotland, there is a growing perception that private diagnosis represents a form of queue jumping, where those with the means to pay bypass the waiting lists that others must endure. This view has hardened into policy in some areas, with local health boards instructing GPs not to accept shared care from private providers at all, regardless of the quality of the assessment. The result is that patients who believed they had secured a stable treatment pathway are now finding themselves cut adrift.

The scale of the problem is vast. Across the UK, more than 500,000 people are waiting for an ADHD assessment, and Scottish services are particularly strained. When shared care agreements collapse, patients face a choice between paying hundreds of pounds each month for medication or stopping treatment altogether, often after years of stability.

Understanding the NAIT Guidance: The Gatekeeper for Shared Care

The NAIT guidance is the single most important document shaping ADHD shared care in Scotland, yet most patients have never read it. Understanding what it requires is essential if you hope to challenge a refusal.

The guidance sets out a framework for what constitutes a robust private assessment. It requires that the diagnosing clinician gather collateral information from someone who knew the patient during childhood, take a thorough cardiac history and arrange an ECG if indicated, and provide a clear ongoing monitoring plan that specifies who is responsible for physical health checks, dose titration, and review appointments. The assessment must follow SIGN guidelines and the standards set by the Royal College of Psychiatrists in Scotland.

The problem is that many private assessments fall short of these requirements. The NAIT guidance itself notes the variability and unpredictability of private practice, pointing out that some providers offer brief, single-appointment assessments without the depth of information that an NHS service would gather over multiple sessions. When a GP receives a shared care request backed by a thin report lacking childhood history or a proper cardiac workup, the NAIT guidance gives them a clear, defensible reason to say no.

Legally, GPs are not obliged to accept shared care agreements. The decision rests with the individual GP, who must be satisfied that the private diagnosis is sound and that the prescribing responsibility is safe to take on. The NAIT framework does not compel GPs to refuse, but it arms them with a checklist that many private assessments cannot satisfy. This is the crucial difference from England’s Right to Choose pathway, where the NHS commissions private providers directly and the assessment is treated as an NHS diagnosis from the outset. In Scotland, no such pathway exists, and the private diagnosis stands or falls on its own merits.

Why Your GP Might Withdraw an Existing Shared Care Agreement

Perhaps the most destabilising scenario is the withdrawal of an agreement that has been in place for years. Patients who have been stable on medication, sometimes for three years or more, are receiving letters giving six months’ notice that their GP will no longer prescribe. The justification is often a change in practice policy or a directive from the local health board.

There is a cruel irony at work here. When shared care collapses, patients are forced back onto NHS waiting lists for a re-assessment, and those waiting lists are already clogged. The Guardian reported in January 2026 that returning private patients are contributing to the backlog, not reducing it. The NHS is overspending by £164 million a year on ADHD services, with a growing proportion of that money going to private assessments that do not ultimately relieve pressure on the system.

Some health boards have introduced what amount to blanket bans on shared care from private providers. Trust-level policies override individual GP discretion, leaving patients with no avenue for negotiation at the practice level. The cost burden shifts entirely onto the patient, and for many, the sums are simply unaffordable.

What to Do If Your Shared Care Is Withdrawn: A Step-by-Step Guide

If you have received notice that your shared care agreement is ending, or if your GP has refused to enter into one after a private diagnosis, there are concrete steps you can take. The situation is serious, but it is not always hopeless.

Step one is to request a formal review of the decision from your GP practice. Write a letter, not an email, and address it to the practice manager. Reference the NAIT guidance directly and ask the GP to specify exactly which elements of your private assessment they consider insufficient. If your assessment did include childhood collateral, a cardiac screen, and a monitoring plan, point this out clearly. Many refusals are generic; forcing the practice to articulate specific clinical concerns can sometimes reveal that the refusal is policy-driven rather than evidence-based, which gives you grounds for escalation.

Step two is to contact your local NHS Health Board’s adult ADHD service directly. Ask for current waiting times for a re-assessment and enquire about the possibility of a bridging prescription. Some services, though stretched, will issue short-term prescriptions to prevent a treatment gap while you wait for an appointment. This is not guaranteed, but it is always worth asking, and having the request documented helps build a paper trail.

Step three is to seek independent advocacy. In Scotland, the Patient Advice and Support Service, known as PASS, offers free, confidential advice and can help you navigate complaints procedures. They can attend meetings with you and help you frame your case in terms that the NHS system recognises. A well-argued complaint that cites the NAIT guidance and demonstrates that your private assessment meets its standards carries more weight than an emotional appeal.

Step four is to consider, if your finances allow, switching to a private psychiatrist who offers remote prescribing as a temporary bridge. This is not a long-term solution, but it can keep you on medication while you pursue an NHS re-assessment or challenge the shared care withdrawal. Some private providers offer reduced rates for prescription-only appointments, though the medication cost itself remains significant.

Step five is to document everything. Keep copies of your original private assessment report, all correspondence with your GP and health board, your prescription history, and notes of any phone calls. If you end up on an NHS waiting list and suffer a treatment gap, this documentation will be essential for any formal complaint or appeal.

Can You Go Back to the NHS Waiting List?

The short answer is yes, but the reality is grim. Waiting times for adult ADHD services in Scotland vary by health board, but six to eighteen months is common, and the BBC reported earlier in 2026 that some services are effectively shutting the door to new NHS patients due to overwhelming demand.

The risk of a treatment gap is real and dangerous. If your shared care ends and you cannot afford private prescriptions, you will run out of medication long before an NHS appointment materialises. For many adults with ADHD, this means a sudden loss of the executive function support that medication provides, affecting their work, relationships, and mental health.

There is also the re-assessment problem. The NHS may not accept your private diagnosis at face value, even if it was thorough. You could find yourself starting from scratch, undergoing a full new assessment, and waiting months for titration even after the initial appointment. Some health boards are more accommodating than others, and regional variation is significant, but the trend across Scotland is towards stricter gatekeeping, not less.

The Hidden Costs of Private Diagnosis: Is It Worth the Risk?

Given the current climate, anyone considering a private ADHD assessment in Scotland must weigh the risks carefully. The upfront cost of a private assessment typically ranges from £500 to £1,500, and that is just the beginning. If shared care is refused, ongoing private prescription costs can easily reach £200 to £300 per month, plus the cost of mandatory review appointments with the private psychiatrist, which may be required every six to twelve months.

The financial comparison over a year is stark. A private pathway with no shared care can cost £3,000 to £5,000 annually, compared to NHS prescription charges of less than £120 per year for those who pay. Even with a prepayment certificate, the difference is enormous.

Beyond the money, there is the emotional toll. The anxiety of waiting to see whether your GP will accept shared care, the frustration of being caught between two systems that seem designed not to communicate, and the loss of stability when an agreement is withdrawn after years of successful treatment, all take a heavy psychological toll. For a condition that already affects emotional regulation, this uncertainty can be particularly damaging.

It is worth noting a significant gap in the available research: there are no published statistics on shared care refusal rates in Scotland, no demographic breakdown of who is most affected, and no data on the clinical outcomes of patients who experience treatment gaps. This absence of evidence makes it harder for patients and advocates to press for change, and it means that individual stories, shared on platforms like Reddit and in patient advocacy groups, carry disproportionate weight in the public conversation.

Frequently Asked Questions

Why do GPs refuse shared care for ADHD in Scotland?

GPs refuse shared care primarily because of the NAIT guidance, which sets standards that many private assessments do not meet. Capacity pressures, local health board policies, and a perception that private diagnosis constitutes queue jumping also play significant roles.

Can I get NHS prescriptions after a private ADHD diagnosis?

Only if your GP agrees to a shared care agreement, and this is becoming increasingly rare in Scotland. Without shared care, you must continue paying for private prescriptions at full cost.

What is the difference between Right to Choose and private diagnosis?

Right to Choose is an NHS-commissioned pathway available in Scotland, where patients can select an approved private provider and the NHS funds the assessment. This pathway does not exist in Scotland. A private diagnosis in Scotland is self-funded and carries no guarantee of NHS recognition.

How long are ADHD waiting lists in Scotland?

Waiting times vary by health board, but adult services typically report waits of six to eighteen months. Some areas have closed their lists entirely to new referrals, redirecting patients to already overstretched neighbouring boards.

Is private ADHD diagnosis worth it in 2026?

It can be, but only if you can afford ongoing private prescriptions indefinitely or are prepared for the possibility of a treatment gap. Before committing, ask the private provider whether their assessments meet NAIT standards and whether they have a track record of successful shared care agreements with Scottish GPs.

The Future of ADHD Care in Scotland: What’s Next

The current situation is unsustainable, and change is inevitable, though its direction remains unclear. Some English health boards have experimented with vetting services that assess private providers against NHS standards before allowing shared care, a model that could reduce the postcode lottery in Scotland if adopted. The Scottish Government has so far not intervened to standardise shared care policies, but pressure is building from patient advocacy groups and the grassroots communities that have formed around this issue.

What is urgently needed is better data. Without clear statistics on refusal rates, patient demographics, and the clinical consequences of treatment gaps, policymakers are operating in the dark. For now, patients must navigate the system as best they can, armed with knowledge of the NAIT guidance, a clear paper trail, and the understanding that they are not alone in facing this crisis.